Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1025 of 1294 entries
View as:

An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

Phase: N/A Priority: Normal
NCT ID: NCT01009905 Org: User:
Start: 06/24/02 End: 09/30/16 Due: 09/30/17

Efficacy of Repaglinide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01698931 Org: User:
Start: 04/26/02 End: 03/06/03 Due: 03/06/04

A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05046873 Org: User:
Start: 09/06/21 End: 01/05/22 Due: 01/05/23

Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01565408 Org: User:
Start: 03/31/12 End: 10/31/13 Due: 10/31/14

Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01536028 Org: User:
Start: 04/30/06 End: 07/31/06 Due: 07/31/07

Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01542463 Org: User:
Start: 09/30/04 End: 07/31/07 Due: 07/31/08

A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years

Phase: N/A Priority: Normal
NCT ID: NCT01789086 Org: User:
Start: 02/28/13 End: 05/31/14 Due: 05/31/15

The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

Phase: N/A Priority: Normal
NCT ID: NCT01664247 Org: User:
Start: 10/01/12 End: 12/31/13 Due: 12/31/14

Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01973231 Org: User:
Start: 10/31/13 End: 11/30/14 Due: 11/30/15

Special Survey for Paediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01487382 Org: User:
Start: 04/30/02 End: 10/31/09 Due: 10/31/10

A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times

Phase: N/A Priority: Normal
NCT ID: NCT04513704 Org: User:
Start: 08/28/20 End: 05/26/21 Due: 05/26/22

Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group

Phase: N/A Priority: Normal
NCT ID: NCT01511185 Org: User:
Start: 02/28/01 End: 10/31/01 Due: 10/31/02

A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together

Phase: N/A Priority: Normal
NCT ID: NCT03789578 Org: User:
Start: 01/17/19 End: 10/10/19 Due: 10/10/20

Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02137850 Org: User:
Start: 06/26/14 End: 06/07/23 Due: 06/07/24

Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03144271 Org: User:
Start: 06/11/07 End: 10/08/07 Due: 10/08/08

A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)

Phase: N/A Priority: Normal
NCT ID: NCT01868542 Org: User:
Start: 06/30/13 End: 05/31/15 Due: 05/31/16

A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

Phase: N/A Priority: Normal
NCT ID: NCT02845219 Org: User:
Start: 07/31/16 End: 12/31/16 Due: 12/31/17

Pharmacokinetics of Insulin Detemir in Healthy Chinese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01498939 Org: User:
Start: 08/31/07 End: 09/30/07 Due: 09/30/08

Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02022254 Org: User:
Start: 12/17/13 End: 08/28/14 Due: 08/28/15

Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT04074161 Org: User:
Start: 09/11/19 End: 05/11/21 Due: 05/11/22

A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03010475 Org: User:
Start: 01/05/17 End: 08/09/17 Due: 08/09/18

Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01720303 Org: User:
Start: 09/19/02 End: 04/10/03 Due: 04/10/04

Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT01068652 Org: User:
Start: 03/31/10 End: 05/31/12 Due: 05/31/13

A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06718998 Org: User:
Start: 11/20/24 End: 11/03/25 Due: 11/03/26

Paediatric Subjects - Special Survey

Phase: N/A Priority: Normal
NCT ID: NCT01538576 Org: User:
Start: 12/31/03 End: 10/31/09 Due: 10/31/10